• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    5.910 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 28, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)
    Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) emerged in the 2010s as one of the pioneers in leveraging artificial intelligence (AI) and advanced data analytics to transform drug discovery and... 
    Via MarketMinute
    Topics Artificial Intelligence
    Is Recursion Pharmaceuticals Gaining or Losing Market Support?
     
    Via Benzinga
    Why Is Recursion Pharma Stock Surging On Monday?
    Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding unexpectedly well to treatment. 
    Via Benzinga
    Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday
     
    Via Benzinga
    Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Jensen Huang's Nvidia Owns 6 Stocks. Here's the Best of the Bunch.
    Via The Motley Fool
    Topics Artificial Intelligence Initial Public Offering Intellectual Property
    10 Under-the-Radar Tech Stocks With Incredible Growth Potential
    Just because it's not a household name doesn't mean it's not a magnificent investment. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Here's Why Shares in Recursion Pharmaceuticals Surged Today
    Via The Motley Fool
    Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
     
    Via Benzinga
    Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
    Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments. 
    Via Benzinga
    The Hottest 10 Artificial Intelligence (AI) Stocks on the Market
    This group of companies reflects most of the industry's past, present, and future. 
    Via The Motley Fool
    Topics Artificial Intelligence
    Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:MSFT),(NASDAQ:ASTH),(NASDAQ:RXRX),(NASDAQ:MDAI) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Artificial Intelligence Fraud
    Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...'
    Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery. 
    Via Benzinga
    Topics Artificial Intelligence
    What Analysts Are Saying About Recursion Pharmaceuticals Stock
     
    Via Benzinga
    Is the Market Bullish or Bearish on Recursion Pharmaceuticals?
     
    Via Benzinga
    Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health
    Issued on behalf of Avant Technologies Inc. Vancouver, BC – June 17, 2025 – USA News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable... 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts
     
    Via Benzinga
    Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy?
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence Intellectual Property
    Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday
    Via The Motley Fool
    Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening?
    Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher and trending. The company on Tuesday announced a reduction in personnel and infrastructure aimed at extending its cash runway. 
    Via Benzinga
    Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
     
    Via Benzinga
    Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Ahead
    The company now expects its projected cash runway to extend into the fourth quarter of 2027. 
    Via Stocktwits
    Topics Artificial Intelligence Workforce
    Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?
     
    Via Benzinga
    Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT
    Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict... 
    Via Benzinga
    Topics Artificial Intelligence
    MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    3 Monster Stocks to Hold for the Next 10 Years
    A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most. 
    Via The Motley Fool
    Topics Energy
    8 Health Care Stocks With Whale Alerts In Today's Session
     
    Via Benzinga
    These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
    While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns. 
    Via MarketBeat
    Topics Artificial Intelligence Earnings
    Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.